{"id":"W3008187114","doi":"10.1200/jco.2020.38.6_suppl.tps586","title":"INTACT: Phase III randomized trial of concurrent chemoradiotherapy with or without atezolizumab in localized muscle invasive bladder cancer—SWOG/NRG1806.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Atezolizumab; Gemcitabine; Clinical endpoint; Urology; Oncology; Radiation therapy; Chemoradiotherapy; Internal medicine; Surgery; Cancer; Randomized controlled trial; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002119741,0.002030792,0.002479651,0.0004240792,0.0003654747,0.001254498,0.001266459,0.001684658,0.0128321],"category_scores_gemma":[0.001565326,0.00065316,0.001813767,0.0004408529,0.001099558,0.001236281,0.0006500999,0.003642057,0.001945484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008189197,"about_ca_system_score_gemma":0.00125699,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001245223,"about_ca_topic_score_gemma":0.003143936,"domain_scores_codex":[0.9994721,0.0002929031,0.00002669627,0.00008735317,0.00003628644,0.0000846618],"domain_scores_gemma":[0.9991469,0.0001814988,0.0001944863,0.00007686337,0.00004532176,0.0003547607],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9800873,0.004674771,0.0003920113,0.0004789515,0.0005072176,0.00002391585,0.00003250525,0.0004354499,0.001387457,0.0001263581,0.00116325,0.01069086],"study_design_scores_gemma":[0.9545336,0.04328337,0.0007232441,0.0000245028,0.0002252173,0.00002478944,0.00001527488,0.000366872,0.0001438748,0.0001286004,0.0005229718,0.000007790313],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.97741,0.005126324,0.0009666166,0.001528691,0.0009918493,0.006123552,0.003577367,0.0003152801,0.003960192],"genre_scores_gemma":[0.9677474,0.003092699,0.002884964,0.002927134,0.0007506563,0.009023133,0.004669952,0.00007680756,0.008827201],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0128321,"threshold_uncertainty_score":0.04292768,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1448530786885959,"score_gpt":0.4884129881730352,"score_spread":0.3435599094844393,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}